Coronary Disease  >>  ranolazine ER  >>  Phase 4
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ranolazine ER / Generic mfg.
NCT00832572: Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy

Terminated
4
5
US
Ranolazine, Ranexa, Placebo
Gilead Sciences
Coronary Artery Disease, Pain, Peripheral Nervous System Diseases, Polyneuropathy
06/09
06/09
NCT01221272 / 2011-001516-54: Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging

Completed
4
81
US, Canada, Europe, RoW
Ranolazine, Ranexa®, Placebo to match ranolazine, SPECT MPI, Exercise
Gilead Sciences
Myocardial Perfusion Imaging, Myocardial Ischemia
09/12
09/12
NCT01334203: A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)

Withdrawn
4
0
US, Canada, Europe, RoW
Ranolazine, Ranexa
Gilead Sciences
Angina Pectoris, Coronary Artery Disease, Type 2 Diabetes Mellitus
10/12
12/12
TERISA, NCT01425359 / 2011-002273-29: Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

Completed
4
949
US, Canada, Europe, RoW
Ranolazine, Ranexa®, Ranolazine placebo
Gilead Sciences
Angina Pectoris, Coronary Artery Disease, Type 2 Diabetes Mellitus
10/12
10/12
NCT02423265: Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries

Withdrawn
4
0
US
Ranolazine, Renexa, Placebo
East Carolina University, Gilead Sciences
Myocardial Ischemia, Coronary Artery Disease, Arteriosclerosis, Chronic Stable Angina
12/16
03/17

Download Options